We are live on ! Find out more
TRIV

TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV

Delisted

TRIV was delisted on the 3rd of February, 2016.

36 hedge funds and large institutions have $79.6M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 3836 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

47% less capital invested

Capital invested by funds: $149M → $79.6M (-$69.2M)

Holders
36
Holders Change
-2
Holders Change %
-5.26%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
12
Reduced
10
Closed
11
Calls
Puts
Net Calls
Net Calls Change

TRIV Hedge Fund Activity: Q2 2015 in Review

36 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q2 2015, worth a combined $79.6M — down 47% from $149M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of TRIV and 9 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was Wellington Management Group, adding an estimated $8.83M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.4M sold.

  • 36 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q2 2015, down from 38 in Q1 2015.
  • Funds reported $79.6M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q2 2015, down 47% quarter-over-quarter.
  • 9 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q2 2015 and 11 closed out, a net change of -2 holders.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q2 2015 was Wellington Management Group, an estimated $8.83M added.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q2 2015 was Deerfield Management, an estimated $10.4M sold.

Based on aggregated 13F filings for Q2 2015.